Home Lexent Bio

Lexent Bio

acquired
-
Liquid Biopsy Technology Developer

Basic Information

Lexent Bio is a professional team of clinicians, scientists, and engineers proudly dedicated to translating scientific advancements into cost-effective and scalable clinical practices. Lexent Bio is developing novel liquid biopsy technologies to transform the way we diagnose and treat cancer. Currently, Lexent Bio is working on technologies that will enable clinicians to monitor patients' responses to treatment faster than imaging, quickly identifying the most effective treatment options.
Lexent Bio, Inc.
SanFrancisco,California,United States of America
15~50 people
January 01, 2016
contact@lexentbio.com